Mary S Soderstrom, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1460 Walnut St, Columbus, TX 78934 Phone: 979-732-6204 |
News Archive
Cell therapies being developed to treat a range of conditions could be improved by a chemical compound that aids their survival, research suggests.
ToolGen, Inc., a biotechnology company specializing in genome editing, today announced data demonstrating that blocking a molecular pathway that down-regulates T-cell activity with the Company's CRISPR/Cas9 gene editing platform results in increased T-cell receptor signaling, in vitro, and in improved anti-tumor activity when tested against in a mouse glioblastoma tumor model.
Continuation of community-wide HIV testing and prompt initiation of treatment as delivered in the HPTN 071 study in South Africa and Zambia could lead to substantial reductions in new HIV cases, be cost-effective, and help to achieve the UNAIDS 2030 targets, according to projections from mathematical modeling and cost-effectiveness analyses presented today at the 10th International AIDS Society Conference on HIV Science in Mexico City.
A new study published in mBio discusses the microevolution of SARS-CoV-2.
Bipolar disorder (BD) is a debilitating psychiatric disorder characterized by fluctuating periods of depression and mania.
› Verified 5 days ago